In the present work, we obtained polymeric diacetylene liposomes that can associate N-Acetyl-L-Cysteine (NAC),a broad spectrum mucolytic. The reason for studying these formulations is that they could be applied in thefuture as NAC delivery systems, with a possible dose reduction but maintaining its effect.Liposomes used herein are obtained by a photopolymerization reaction, thus gaining stability and rigidity.Lipids belonging to lung surfactant were added in different ratios to the formulations in order to maximize itspossible interaction with the lung tissue. Because of lipopolymer stability, the oral or nasal route could beappropriated. This formulation could efficiently transport NAC to exert its mucolytic activity and help in diseasessu...
The administration of hydrophobic actives and drugs for medical or cosmetical purposes generally req...
International audienceDiseases affecting the respiratory tract are numerous and many are disabling o...
The ultimate goal of drug delivery is to increase the bioavailability and reduce the toxic side effe...
The physicochemical characterization of polymer liposome complexes (PLCs) prepared with lipids of la...
Cystic fibrosis (CF) is the most common autosomal recessive disorder affecting Caucasian populations...
The development of new polymer–liposome complexes (PLCs) as delivery systems is the key issue of thi...
Nuclear factor-kappaB (NF-kappaB) is involved in several pathological processes, such as inflammatio...
Biological and medical applications of liposomes as carriers for cytostatic drugs, magnetic-resonanc...
The influence of the presence of synthetic structurally related N-oxide and corresponding cationic s...
The use of nucleic acids is a promising therapeutic approach in nanomedicine, in particular with the...
Aims: In this work, we developed and characterized liposomal formulations that encapsulate L-cystein...
Nuclear factor-kappa B (NF-kappa B) is involved in several pathological processes, Such as inflammat...
The aim of this work was the development of microstructured lipid carriers (MLC) based on chitosan (...
: Mycobacterium abscessus (Mabs) is a dangerous non-tubercular mycobacterium responsible for severe ...
The administration of hydrophobic actives and drugs for medical or cosmetical purposes generally req...
International audienceDiseases affecting the respiratory tract are numerous and many are disabling o...
The ultimate goal of drug delivery is to increase the bioavailability and reduce the toxic side effe...
The physicochemical characterization of polymer liposome complexes (PLCs) prepared with lipids of la...
Cystic fibrosis (CF) is the most common autosomal recessive disorder affecting Caucasian populations...
The development of new polymer–liposome complexes (PLCs) as delivery systems is the key issue of thi...
Nuclear factor-kappaB (NF-kappaB) is involved in several pathological processes, such as inflammatio...
Biological and medical applications of liposomes as carriers for cytostatic drugs, magnetic-resonanc...
The influence of the presence of synthetic structurally related N-oxide and corresponding cationic s...
The use of nucleic acids is a promising therapeutic approach in nanomedicine, in particular with the...
Aims: In this work, we developed and characterized liposomal formulations that encapsulate L-cystein...
Nuclear factor-kappa B (NF-kappa B) is involved in several pathological processes, Such as inflammat...
The aim of this work was the development of microstructured lipid carriers (MLC) based on chitosan (...
: Mycobacterium abscessus (Mabs) is a dangerous non-tubercular mycobacterium responsible for severe ...
The administration of hydrophobic actives and drugs for medical or cosmetical purposes generally req...
International audienceDiseases affecting the respiratory tract are numerous and many are disabling o...
The ultimate goal of drug delivery is to increase the bioavailability and reduce the toxic side effe...